Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
West China Hospital
Orano Med LLC
Technische Universität Dresden
Amgen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Taiwan University Hospital
Providence Health & Services
National Cancer Institute (NCI)
Melanoma and Skin Cancer Trials Limited
National Cancer Center Hospital East
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
ITM Solucin GmbH
Washington University School of Medicine
Melanoma and Skin Cancer Trials Limited
Hoffmann-La Roche
Legend Biotech USA Inc
University Health Network, Toronto
Novartis
M.D. Anderson Cancer Center